MR
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
27.673
Exchange
XNAS - Nasdaq
8 %
Last period Net income growth rate
49%
Net income growth rate has increased in 5 years
What is Net income growth rate ?
An indicator of the company's profit growth rate relative to the same periods of previous years.
See also Moderna
Company Analysis
MRNA valuation, rating, competitors, insights and company profile
Eyestock Rating
MRNA financial analysis by Eyestock methodology
Valuation
MRNA valuation using historical relative method
Statements
MRNA Income Statements, Balance Sheet and Cash Flow Statements
Dividends
MRNA dividend yield and annual dividend
An indicator of the company's profit growth rate relative to the same periods of previous years.
Moderna`s Net income growth rate for the period ended 2024-06-30 is 8 %
